Intellectual Property India Publishes Patent Application for 'DLL3 Binding Molecules And Uses Thereof' Filed by Abdera Therapeutics Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517023520 A) filed by Abdera Therapeutics Inc., San Francisco, on March 17, for 'dll3 binding molecules and uses thereof.'

Inventor(s) include Abrams, Michael J.; Cummins, Emma Jane; Judge, Adam Daniel; Mandel, Alexander Laurence; and Viswas, Raja Solomon.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "Described herein are heavy chain antibodies that bind to DLL3 and immunoconjugates of DLL3 heavy chain antibodies useful for cancer therapy."

The patent application was internationally filed on Aug. 21, 2023, under International application No.PC...